XML 15 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 25, 2021
Sep. 26, 2020
Sep. 25, 2021
Sep. 26, 2020
Revenues:        
Total revenues $ 10,887,173 $ 9,512,752 $ 32,468,797 $ 26,206,003
Expenses:        
Cost of product revenues 5,145,175 4,825,032 17,586,389 15,252,456
Research and development 3,751,729 2,715,868 11,055,282 7,276,770
Selling, general and administration 4,035,998 3,079,567 13,982,682 9,421,024
Total expenses 12,932,902 10,620,467 42,624,353 31,950,250
Loss from operations (2,045,729) (1,107,715) (10,155,556) (5,744,247)
Other (expense) income:        
Interest income 9,959 12,751 22,244 120,187
Other expense, net (31,529) (28,600) (33,574) (65,680)
Foreign currency transaction (losses) gains (29,384) 183,795 100,597 20,797
Total other income and expense (50,954) 167,946 89,267 75,304
Loss before provision for income taxes and net loss attributable to noncontrolling interest (2,096,683) (939,769) (10,066,289) (5,668,943)
Tax provision (32,000) (29,000) (97,000) (100,000)
Net loss (2,128,683) (968,769) (10,163,289) (5,768,943)
Net (income) loss attributable to the noncontrolling interest (107) 11,329 39,394 94,443
Net loss attributable to Kopin Corporation $ (2,128,790) $ (957,440) $ (10,123,895) $ (5,674,500)
Net loss per share        
Basic and diluted $ (0.02) $ (0.01) $ (0.11) $ (0.07)
Weighted average number of common shares outstanding        
Basic and diluted 90,517,330 82,596,416 88,903,658 82,567,401
Net Product Revenues [Member]        
Revenues:        
Total revenues $ 6,591,852 $ 6,487,581 $ 21,089,515 $ 19,077,090
Research and Development Revenues [Member]        
Revenues:        
Total revenues $ 4,295,321 $ 3,025,171 $ 11,379,282 $ 7,128,913